SON Stock Analysis: Sonoco Products | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 5.677m USD | 12M Return: 68.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 66.1M
EPS Trend: 21.7%
Qual. Beats: 0
Rev. Trend: -3.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sonoco Products Company (NYSE: SON) is a global manufacturer of engineered and sustainable packaging products, operating across the United States, Europe, Canada, and the Asia Pacific. Founded in 1899 and headquartered in Hartsville, South Carolina, the company is classified within the GICS Materials sector under the Paper & Plastic Packaging Products & Materials sub-industry.
The business is organized into two reporting segments. The Consumer Packaging segment produces rigid paper, steel, and plastic containers, along with metal and peelable membrane ends, closures, and components. The Industrial Paper Packaging segment supplies paperboard tubes, cones, and cores, paper-based protective packaging, and uncoated recycled paperboards. Sonoco also distributes a broader range of packaging materials, including plastic, paper, and foam specialty products, serving diverse end markets such as food, construction, textiles, film, wire and cable, and general industrial applications.
Sonocos diversified segment structure and emphasis on sustainable packaging materials are consistent with broader trends in the global packaging industry, where manufacturers are balancing demand for fiber-based and recyclable solutions with cost pressures in paper and raw material inputs.
- Eviosys acquisition expands metal packaging footprint
- Consumer Packaging margins face steel and resin cost pressure
- Industrial Paper Packaging volumes weaken on construction and textile slowdown
| Net Income: 1.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.93 > 1.0 |
| NWC/Revenue: -1.39% < 20% (prev -15.08%; Δ 13.70% < -1%) |
| CFO/TA 0.05 > 3% & CFO 529.9m > Net Income 1.04b |
| Net Debt (4.99b) to EBITDA (1.52b): 3.28 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.7m) vs 12m ago 0.36% < -2% |
| Gross Margin: 20.92% > 18% (prev 21.49%; Δ -0.56% > 0.5%) |
| Asset Turnover: 63.04% > 50% (prev 42.40%; Δ 20.63% > 0%) |
| Interest Coverage Ratio: 4.50 > 6 (EBIT TTM 998.0m / Interest Expense TTM 222.0m) |
| A: -0.01 (Total Current Assets 2.74b - Total Current Liabilities 2.85b) / Total Assets 11.1b |
| B: 0.31 (Retained Earnings 3.39b / Total Assets 11.1b) |
| C: 0.08 (EBIT TTM 998.0m / Avg Total Assets 11.9b) |
| D: 0.48 (Book Value of Equity 3.59b / Total Liabilities 7.48b) |
| Altman-Z'' = 2.01 = BBB |
| DSRI: 0.68 (Receivables 1.12b/1.19b, Revenue 7.49b/5.38b) |
| GMI: 1.03 (GM 21.49% / 20.92%) |
| AQI: 0.94 (AQ_t 0.48 / AQ_t-1 0.50) |
| SGI: 1.39 (Revenue 7.49b / 5.38b) |
| TATA: 0.05 (NI 1.04b - CFO 529.9m) / TA 11.1b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of July 07, 2026, the stock is trading at USD 57.00 with a total of 632,526 shares traded. Over the past week, the price has changed by +1.46%, over one month by +10.20%, over three months by +9.01% and over the past year by +68.81%.
Current recommended Stop Loss: 53.70 (which is 5.8% or 2.1 ATR below the current price).
Sonoco Products has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy SON.
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 60.9 | 6.8% |
P/E Trailing = 9.3977
P/E Forward = 10.0604
P/S = 0.7584
P/B = 1.5556
P/EG = 0.2027
Revenue TTM = 7.49b USD
EBIT TTM = 998.0m USD
EBITDA TTM = 1.52b USD
Long Term Debt = 3.49b USD (from longTermDebt, last quarter)
Short Term Debt = 1.20b USD (from shortTermDebt, last quarter)
Debt = 5.22b USD (from shortLongTermDebtTotal, last quarter) + Leases 264.6m
Net Debt = 4.99b USD (calculated: Debt 5.22b - CCE 224.5m)
Enterprise Value = 10.7b USD (5.68b + Debt 5.22b - CCE 224.5m)
Interest Coverage Ratio = 4.50 (Ebit TTM 998.0m / Interest Expense TTM 222.0m)
EV/FCF = 40.15x (Enterprise Value 10.7b / FCF TTM 265.8m)
FCF Yield = 2.49% (FCF TTM 265.8m / Enterprise Value 10.7b)
FCF Margin = 3.55% (FCF TTM 265.8m / Revenue TTM 7.49b)
Net Margin = 13.83% (Net Income TTM 1.04b / Revenue TTM 7.49b)
Gross Margin = 20.92% ((Revenue TTM 7.49b - Cost of Revenue TTM 5.92b) / Revenue TTM)
Gross Margin QoQ = 20.62% (prev 19.63%)
Tobins Q-Ratio = 0.96 (Enterprise Value 10.7b / Total Assets 11.1b)
Interest Expense / Debt = 4.25% (Interest Expense 222.0m / Debt 5.22b)
Taxrate = 22.01% (171.9m / 781.3m)
NOPAT = 778.3m (EBIT 998.0m * (1 - 22.01%))
Current Ratio = 0.96 (Total Current Assets 2.74b / Total Current Liabilities 2.85b)
Debt / Equity = 1.46 (Debt 5.22b / totalStockholderEquity, last quarter 3.59b)
Debt / EBITDA = 3.28 (Net Debt 4.99b / EBITDA 1.52b)
Debt / FCF = 18.79 (Net Debt 4.99b / FCF TTM 265.8m)
Total Stockholder Equity = 3.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.72% (Net Income 1.04b / Total Assets 11.1b)
RoE = 30.14% (Net Income TTM 1.04b / Total Stockholder Equity 3.44b)
RoCE = 14.42% (EBIT 998.0m / Capital Employed (Equity 3.44b + L.T.Debt 3.49b))
RoIC = 8.46% (NOPAT 778.3m / Invested Capital 9.20b)
WACC = 5.51% (E(5.68b)/V(10.9b) * Re(7.52%) + D(5.22b)/V(10.9b) * Rd(4.25%) * (1-Tc(0.22)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 0.24%
[DCF] Terminal Value 77.97% ; FCFF base≈183.5m ; Y1≈210.4m ; Y5≈309.6m
[DCF] Fair Price = N/A (negative equity: EV 4.66b - Net Debt 4.99b = -335.1m; debt exceeds intrinsic value)
EPS Correlation: 21.66 | EPS CAGR: 1.49% | SUE: 0.03 | # QB: 0
Revenue Correlation: -3.73 | Revenue CAGR: -0.52% | SUE: -0.08 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.49 | Chg30d=-5.19% | Revisions=-75% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.95 | Chg30d=-2.92% | Revisions=-15% | Analysts=10
EPS current Year (2026-12-31): EPS=5.82 | Chg30d=-2.27% | Revisions=-77% | GrowthEPS=+2.0% | GrowthRev=-1.0%
EPS next Year (2027-12-31): EPS=6.41 | Chg30d=-2.24% | Revisions=-46% | GrowthEPS=+10.1% | GrowthRev=+2.1%
[Analyst] Revisions Ratio: -64% (up=6, down=33)